Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FM183
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,233
Award facts
- Contract value 100% obligated
- $13,232.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,232.81 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 15, 2026, with an ultimate completion date of January 16, 2026. This non-set-aside contract is a child order under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program—valued at up to $999,999,999.00 through December 2026. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The parent company, Cencora, Inc. (doing business as Amerisourcebergen), holds the primary IDC and utilizes its subsidiary to fulfill specific delivery orders for pharmaceutical products and medical supplies across multiple therapeutic domains.
As a child delivery order under the DLA's comprehensive pharmaceutical supply vehicle, this contract represents a tactical execution of the broader Pharmaceutical Prime Vendor Global Program, which is designed to supply prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and government healthcare systems worldwide. The competitively awarded structure and firm fixed-price model demonstrate Amerisourcebergen's established capability to meet federal procurement requirements for critical pharmaceutical commodities on a time-sensitive basis.
Quick answers
Who was awarded contract SPE2DU26FM183?
SPE2DU26FM183 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DU26FM183 worth?
The government has obligated $13,233 on SPE2DU26FM183.
Is contract SPE2DU26FM183 an order under another contract?
Yes. SPE2DU26FM183 is a delivery order under SPE2DU25D4118, an indefinite delivery contract.
Was contract SPE2DU26FM183 competed?
The extent of competition for SPE2DU26FM183 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award